The national and subnational burden attributable to high body mass index in Iran from 1990 to 2021: a systematic analysis of the global burden of disease study

1990年至2021年伊朗高体重指数造成的国家和地方疾病负担:全球疾病负担研究的系统分析

阅读:1

Abstract

BACKGROUND: High body mass index (BMI) remains a critical public health issue, significantly burdening healthcare systems. This study aimed to evaluate the burden of high BMI and its related causes in Iran from 1990 to 2021. METHODS: Data from the Global Burden of Disease (GBD) 2021 project were used to assess the burden attributable to high BMI in Iran. Measures included years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life years (DALYs), and deaths, presented by cause, age, sex, province, and sociodemographic index (SDI). Summary exposure values (SEVs) were also analyzed to indicate exposure levels. All estimates were reported with 95% uncertainty intervals (UIs). RESULTS: The age-standardized DALYs per 100,000 population attributable to high BMI increased by 39.3% (17.4 to 55.9), from 1570.8 (95% UI: 801.5 to 2356.3) in 1990 to 2188.4 (1020.5 to 3231.0) in 2021. Similarly, the age-standardized death rate rose by 28.2% (6.55 to 46.07), from 55.9 (32.4 to 81.7) in 1990 to 71.6 (39.2 to 106.8) in 2021. For both sexes, the premature death rate (under 70 years) rose from 14.05 (7.66-20.36) in 1990 to 26.42 (13.78-37.97) in 2021. Cardiovascular diseases (CVDs) and diabetes and kidney disorders remained the leading causes of high BMI-related deaths. From 2010 to 2021, low SDI provinces saw greater increases in BMI-attributed death rates compared to 1990-2010. SEV values rose across all age groups from 1990 to 2021, particularly among females aged 60-69. Between 2019 and 2021, SEV changes accelerated compared to 2010-2019. CONCLUSION: The burden of high BMI and related diseases in Iran has increased substantially over the past three decades. This trend highlights the urgent need for targeted public health initiatives to mitigate the health and economic impacts of obesity, particularly addressing disparities related to sex, age, and provincial SDI levels, while focusing on CVDs and diabetes prevention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40200-025-01803-5.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。